Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.910
-0.199 (-3.89%)
Jun 27, 2025, 4:00 PM - Market closed
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $26.24 million as of June 27, 2025. Its market cap has increased by 201.43% in one year.
Market Cap
26.24M
Enterprise Value
20.41M
1-Year Change
201.43%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $26.24M, a decrease of -91.89%. That is a compound annual growth rate of -50.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 27.30M | 192.23% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.29B |
| Johnson & Johnson | 365.89B |
| AbbVie | 330.65B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.76B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.80B |
| AstraZeneca | 216.45B |